Sex-dimorphic moderate hypoglycemia preconditioning effects on Hippocampal CA1 neuron bio-energetic and anti-oxidant function
Authors:
- 10 August 2020
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 473 (1-2) , 39-50
Abstract
Hypoglycemia is a detrimental complication of rigorous management of type 1 diabetes mellitus. Moderate hypoglycemia (MH) preconditioning of male rats partially affords protection from loss of vulnerable brain neurons to severe hypoglycemia (SH). Current research investigated whether MH preconditioning exerts sex-dimorphic effects on hippocampal CA1 neuron bio-energetic and anti-oxidant responses to SH. SH up-regulated CA1 glucose or monocarboxylate transporter proteins in corresponding hypoglycemia-naïve male versus female rats; precedent MH amplified glucose transporter expression in SH irrespective of sex. Sex-differentiating SH effects on glycolytic and tricarboxylic pathway markers correlated with elevated tissue ATP content and diminished CA1 5′-AMP-activated protein kinase (AMPK) activation in females. MH-preconditioned suppression of mitochondrial energy pathway enzyme profiles and tissue ATP in SH rats coincided with amplified CA1 AMPK activity in both sexes. Anti-oxidative stress enzyme protein responses to SH were primarily sex-contingent; preconditioning amplified most of these profiles, yet exacerbated expression of lipid and protein oxidation markers in SH male and female rats, respectively. Results show that MH preconditioning abolishes female CA1 neuron neuroprotection of positive energy balance through SH, resulting in augmented CA1 AMPK activity and oxidative injury and diminished tissue ATP in hypoglycemia-conditioned versus naïve rats in each sex. It is unclear if SH elicits differential rates of CA1 neuronal destruction in the two sexes, or how MH may impact sex-specific cell loss. Further research is needed to determine if molecular mechanism(s) that maintain female CA1 neuron metabolic stability in the absence of MH preconditioning can be leveraged for therapeutic prevention of hypoglycemic nerve cell damage.Keywords
Funding Information
- National Institutes of Health (DK 109382)
This publication has 16 references indexed in Scilit:
- Recurrent moderate hypoglycemia exacerbates oxidative damage and neuronal death leading to cognitive dysfunction after the hypoglycemic comaJournal of Cerebral Blood Flow & Metabolism, 2017
- Hypoglycemia-Associated Autonomic Failure in Diabetes: Maladaptive, Adaptive, or Both?Diabetes, 2015
- Recurrent Moderate Hypoglycemia Ameliorates Brain Damage and Cognitive Dysfunction Induced by Severe HypoglycemiaDiabetes, 2010
- Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- Sequential Release of Nitric Oxide, Zinc, and Superoxide in Hypoglycemic Neuronal DeathJournal of Cerebral Blood Flow & Metabolism, 2008
- Progesterone and Estrogen Regulate Oxidative Metabolism in Brain MitochondriaEndocrinology, 2008
- EstradiolIn VivoRegulation of Brain Mitochondrial ProteomeThe Journal of Neuroscience, 2007
- Hypoglycaemia unawareness and the brainDiabetologia, 2002
- Rat brain glycolysis regulation by estradiol-17βBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- The distribution of hypoglycemic brain damageActa Neuropathologica, 1984